Allergan (Solid Oral Dosage Manufacturing Facility)
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
1
INVESTMENTS
Description
Manufacturer of pharmaceuticals. The company operates a manufacturing facility which is engaged in the production of solid oral dosage pharmaceutical products.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- Morris Corporate Center III
- Parsippany, NJ 07054
- United States
Allergan (Solid Oral Dosage Manufacturing Facility) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Allergan (Solid Oral Dosage Manufacturing Facility)‘s full profile, request access.
Request full access to PitchBookAllergan (Solid Oral Dosage Manufacturing Facility) Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 000000000 | 28-Jan-2010 | 000000000000000000 | 0000 | Biotechnology |
Allergan (Solid Oral Dosage Manufacturing Facility) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Allergan (Solid Oral Dosage Manufacturing Facility)‘s full profile, request access.
Request full access to PitchBook